Macro photography of a clean glass petri dish under cool daylight, sharp focus on crystalline structures, slate and white tones.
Macro photography of a clean glass petri dish under cool daylight, sharp focus on crystalline structures, slate and white tones.
View Publications
/ Clinical Validation

Rigorous science, validated mechanisms.

We translate high-stakes clinical drug development and metabolic research into practical, identity-driven behavioral protocols. No wellness trends, only peer-reviewed health science.

Close-up of a clinical scientist in a crisp white lab coat adjusting a high-precision microscope, cool daylight, slate tones, professional setting.
Close-up of a clinical scientist in a crisp white lab coat adjusting a high-precision microscope, cool daylight, slate tones, professional setting.
+ Scientific Leadership

Led by Clinical Researchers

PhD-Backed Methodology

Our advisory board consists of clinical researchers dedicated to translating laboratory breakthroughs into human optimization. We maintain strict adherence to clinical standards, ensuring every protocol is grounded in metabolic science.

We actively collaborate with university laboratories and clinical trial centers to validate our multi-pathway topical formulations and behavioral lifestyle interventions.

Macro close-up of cellular-like structures under a clinical microscope, sharp focus, clean laboratory daylight, slate and high-visibility signal blue accents.
Macro close-up of cellular-like structures under a clinical microscope, sharp focus, clean laboratory daylight, slate and high-visibility signal blue accents.
/ Evidence Base

Peer-Reviewed Foundations

Active Research Portfolio

Our ongoing FolioScar research programme targets primary cicatricial alopecia with a novel, IP-protected topical formulation. We present our findings transparently to secure institutional funding and research partnerships.

Key Publications & IP

1. Multi-pathway topical interventions in cicatricial alopecia (2024). 2. Behavioral nutrition and burnout mitigation in corporate cohorts (2023). 3. Patent status: EP3948102A1 (Protected).

Backed by Rigor

100%

IP-Protected

PhD

Led Research

Zero

Trend Chasing